Cargando…
Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity
BACKGROUND: Controlled clinical trials of health care interventions are either explanatory or pragmatic. Explanatory trials test whether an intervention is efficacious; that is, whether it can have a beneficial effect in an ideal situation. Pragmatic trials measure effectiveness; they measure the de...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC317298/ https://www.ncbi.nlm.nih.gov/pubmed/14690550 http://dx.doi.org/10.1186/1471-2288-3-28 |
_version_ | 1782121136946937856 |
---|---|
author | Godwin, Marshall Ruhland, Lucia Casson, Ian MacDonald, Susan Delva, Dianne Birtwhistle, Richard Lam, Miu Seguin, Rachelle |
author_facet | Godwin, Marshall Ruhland, Lucia Casson, Ian MacDonald, Susan Delva, Dianne Birtwhistle, Richard Lam, Miu Seguin, Rachelle |
author_sort | Godwin, Marshall |
collection | PubMed |
description | BACKGROUND: Controlled clinical trials of health care interventions are either explanatory or pragmatic. Explanatory trials test whether an intervention is efficacious; that is, whether it can have a beneficial effect in an ideal situation. Pragmatic trials measure effectiveness; they measure the degree of beneficial effect in real clinical practice. In pragmatic trials, a balance between external validity (generalizability of the results) and internal validity (reliability or accuracy of the results) needs to be achieved. The explanatory trial seeks to maximize the internal validity by assuring rigorous control of all variables other than the intervention. The pragmatic trial seeks to maximize external validity to ensure that the results can be generalized. However the danger of pragmatic trials is that internal validity may be overly compromised in the effort to ensure generalizability. We are conducting two pragmatic randomized controlled trials on interventions in the management of hypertension in primary care. We describe the design of the trials and the steps taken to deal with the competing demands of external and internal validity. DISCUSSION: External validity is maximized by having few exclusion criteria and by allowing flexibility in the interpretation of the intervention and in management decisions. Internal validity is maximized by decreasing contamination bias through cluster randomization, and decreasing observer and assessment bias, in these non-blinded trials, through baseline data collection prior to randomization, automating the outcomes assessment with 24 hour ambulatory blood pressure monitors, and blinding the data analysis. SUMMARY: Clinical trials conducted in community practices present investigators with difficult methodological choices related to maintaining a balance between internal validity (reliability of the results) and external validity (generalizability). The attempt to achieve methodological purity can result in clinically meaningless results, while attempting to achieve full generalizability can result in invalid and unreliable results. Achieving a creative tension between the two is crucial. |
format | Text |
id | pubmed-317298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2003 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-3172982004-01-23 Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity Godwin, Marshall Ruhland, Lucia Casson, Ian MacDonald, Susan Delva, Dianne Birtwhistle, Richard Lam, Miu Seguin, Rachelle BMC Med Res Methodol Debate BACKGROUND: Controlled clinical trials of health care interventions are either explanatory or pragmatic. Explanatory trials test whether an intervention is efficacious; that is, whether it can have a beneficial effect in an ideal situation. Pragmatic trials measure effectiveness; they measure the degree of beneficial effect in real clinical practice. In pragmatic trials, a balance between external validity (generalizability of the results) and internal validity (reliability or accuracy of the results) needs to be achieved. The explanatory trial seeks to maximize the internal validity by assuring rigorous control of all variables other than the intervention. The pragmatic trial seeks to maximize external validity to ensure that the results can be generalized. However the danger of pragmatic trials is that internal validity may be overly compromised in the effort to ensure generalizability. We are conducting two pragmatic randomized controlled trials on interventions in the management of hypertension in primary care. We describe the design of the trials and the steps taken to deal with the competing demands of external and internal validity. DISCUSSION: External validity is maximized by having few exclusion criteria and by allowing flexibility in the interpretation of the intervention and in management decisions. Internal validity is maximized by decreasing contamination bias through cluster randomization, and decreasing observer and assessment bias, in these non-blinded trials, through baseline data collection prior to randomization, automating the outcomes assessment with 24 hour ambulatory blood pressure monitors, and blinding the data analysis. SUMMARY: Clinical trials conducted in community practices present investigators with difficult methodological choices related to maintaining a balance between internal validity (reliability of the results) and external validity (generalizability). The attempt to achieve methodological purity can result in clinically meaningless results, while attempting to achieve full generalizability can result in invalid and unreliable results. Achieving a creative tension between the two is crucial. BioMed Central 2003-12-22 /pmc/articles/PMC317298/ /pubmed/14690550 http://dx.doi.org/10.1186/1471-2288-3-28 Text en Copyright © 2003 Godwin et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
spellingShingle | Debate Godwin, Marshall Ruhland, Lucia Casson, Ian MacDonald, Susan Delva, Dianne Birtwhistle, Richard Lam, Miu Seguin, Rachelle Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity |
title | Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity |
title_full | Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity |
title_fullStr | Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity |
title_full_unstemmed | Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity |
title_short | Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity |
title_sort | pragmatic controlled clinical trials in primary care: the struggle between external and internal validity |
topic | Debate |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC317298/ https://www.ncbi.nlm.nih.gov/pubmed/14690550 http://dx.doi.org/10.1186/1471-2288-3-28 |
work_keys_str_mv | AT godwinmarshall pragmaticcontrolledclinicaltrialsinprimarycarethestrugglebetweenexternalandinternalvalidity AT ruhlandlucia pragmaticcontrolledclinicaltrialsinprimarycarethestrugglebetweenexternalandinternalvalidity AT cassonian pragmaticcontrolledclinicaltrialsinprimarycarethestrugglebetweenexternalandinternalvalidity AT macdonaldsusan pragmaticcontrolledclinicaltrialsinprimarycarethestrugglebetweenexternalandinternalvalidity AT delvadianne pragmaticcontrolledclinicaltrialsinprimarycarethestrugglebetweenexternalandinternalvalidity AT birtwhistlerichard pragmaticcontrolledclinicaltrialsinprimarycarethestrugglebetweenexternalandinternalvalidity AT lammiu pragmaticcontrolledclinicaltrialsinprimarycarethestrugglebetweenexternalandinternalvalidity AT seguinrachelle pragmaticcontrolledclinicaltrialsinprimarycarethestrugglebetweenexternalandinternalvalidity |